Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 235

1.

Clinical analysis of pre-existing diabetes mellitus and dipeptidyl peptidase-4 inhibitors in patients with remitting seronegative symmetrical synovitis and pitting edema syndrome.

Horai Y, Origuchi T, Iwanaga N, Tokumitsu J, Ikeoka T, Kuriya G, Izumi Y, Kawakami A.

Mod Rheumatol. 2019 Sep 18:1-5. doi: 10.1080/14397595.2019.1666463. [Epub ahead of print]

PMID:
31500483
2.

Anti-citrullinated protein antibody titre as a predictor of abatacept treatment persistence in patients with rheumatoid arthritis: a prospective cohort study in Japan.

Endo Y, Koga T, Kawashiri SY, Morimoto S, Nishino A, Okamoto M, Eguchi M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Hamada H, Tsuru T, Nagano S, Arinobu Y, Hidaka T, Tada Y, Kawakami A.

Scand J Rheumatol. 2019 Aug 12:1-5. doi: 10.1080/03009742.2019.1627411. [Epub ahead of print]

PMID:
31402744
3.

Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid Arthritis.

Toyama S, Takatani A, Koga T, Eguchi M, Okamoto M, Tsuji S, Endo Y, Shimizu T, Sumiyoshi R, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Furuyama M, Tabuchi M, Kobayashi S, Kanetaka K, Hashisako M, Abe K, Niino D, Sato S, Miyazaki Y, Kawakami A.

Intern Med. 2019 Jul 22. doi: 10.2169/internalmedicine.2782-19. [Epub ahead of print]

4.

A case of neutrophilic dermatosis with MEFV gene variant and abnormal activation of peripheral blood monocytes: a case report.

Otsuka M, Koga T, Sumiyoshi R, Koike Y, Furukawa K, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Daisuke N, Kawakami A.

Immunol Med. 2019 Mar;42(1):45-49. doi: 10.1080/25785826.2019.1625507. Epub 2019 Jun 16.

PMID:
31204589
5.

Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD.

Nakamura T, Satoh-Nakamura T, Nakajima A, Kawanami T, Sakai T, Fujita Y, Iwao H, Miki M, Masaki Y, Okazaki T, Ishigaki Y, Kawano M, Yamada K, Matsui S, Saeki T, Kamisawa T, Yamamoto M, Hamano H, Origuchi T, Hirata S, Tanaka Y, Tsuboi H, Sumida T, Okazaki K, Tanaka M, Chiba T, Mimori T, Umehara H.

Mod Rheumatol. 2019 Jul 11:1-7. doi: 10.1080/14397595.2019.1621475. [Epub ahead of print]

PMID:
31116057
6.

Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: A case report.

Otsuka M, Koga T, Sumiyoshi R, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Daisuke N, Kawakami A.

Medicine (Baltimore). 2019 May;98(18):e15237. doi: 10.1097/MD.0000000000015237.

7.

Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis.

Kawashiri SY, Fujikawa K, Nishino A, Takatani A, Shimizu T, Umeda M, Fukui S, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Mizokami A, Maeda T, Kawakami A.

Int J Rheum Dis. 2019 May;22(5):842-851. doi: 10.1111/1756-185X.13543. Epub 2019 Mar 18.

PMID:
30883001
8.

Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study.

Ichinose K, Kitamura M, Sato S, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Koga T, Kawashiri S, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Lupus. 2019 Apr;28(4):501-509. doi: 10.1177/0961203319829827. Epub 2019 Feb 12.

PMID:
30755146
9.

Novel multiple heterozygous NUDT15 variants cause an azathioprine-induced severe leukopenia in a patient with systemic lupus erythematosus.

Otsuka M, Koga T, Sumiyoshi R, Furukawa K, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Clin Immunol. 2019 Mar;200:64-65. doi: 10.1016/j.clim.2019.02.004. Epub 2019 Feb 8. No abstract available.

PMID:
30742971
10.

Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab.

Aikawa E, Shimizu T, Koga T, Endo Y, Umeda M, Hori T, Irie J, Kuroda K, Eguchi M, Okamoto M, Tsuji S, Takatani A, Igawa T, Sumiyoshi R, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2019 Jun 15;58(12):1781-1785. doi: 10.2169/internalmedicine.2277-18. Epub 2019 Feb 1.

11.

Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.

Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri S, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Lupus. 2019 Mar;28(3):295-303. doi: 10.1177/0961203319826690. Epub 2019 Jan 30.

PMID:
30700214
12.

Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis.

Fukui S, Kuwahara-Takaki A, Ono N, Sato S, Koga T, Kawashiri SY, Iwanaga N, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Migita K, Arinobu Y, Niiro H, Tada Y, Akashi K, Maeda T, Kawakami A.

Sci Rep. 2019 Jan 24;9(1):688. doi: 10.1038/s41598-018-36825-y.

13.

Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practice.

Umeda M, Koga T, Ichinose K, Takatani A, Igawa T, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Aramaki T, Ueki Y, Okada A, Fujikawa K, Matsuoka N, Kawakami A.

Immunol Med. 2018 Dec;41(4):181-186. doi: 10.1080/25785826.2018.1542942. Epub 2019 Jan 11.

PMID:
30632931
14.

Utility of power Doppler ultrasonography for detecting forefoot bursae in early rheumatoid arthritis: A case report.

Endo Y, Koga T, Eguchi M, Okamoto M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Medicine (Baltimore). 2018 Dec;97(51):e13295. doi: 10.1097/MD.0000000000013295.

15.

A Rare Case of Cryopyrin-associated Periodic Syndrome in an Elderly Woman with NLRP3 and MEFV Mutations.

Nakamichi S, Origuchi T, Fukui S, Yoda A, Matsubara H, Nagaura Y, Nishikomori R, Abe K, Migita K, Sakamoto N, Kawakami A, Ozono Y, Maeda T.

Intern Med. 2019 Apr 1;58(7):1017-1022. doi: 10.2169/internalmedicine.1401-18. Epub 2018 Dec 18.

16.

Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.

Kawashiri SY, Origuchi T, Umeda M, Nishino A, Shimizu T, Fukui S, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Maeda T, Kawano M, Yamamoto M, Izumi Y, Kawakami A.

Arthritis Res Ther. 2018 Dec 14;20(1):277. doi: 10.1186/s13075-018-1777-7.

17.

Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.

Terao C, Yoshifuji H, Matsumura T, Naruse TK, Ishii T, Nakaoka Y, Kirino Y, Matsuo K, Origuchi T, Shimizu M, Maejima Y, Amiya E, Tamura N, Kawaguchi T, Takahashi M, Setoh K, Ohmura K, Watanabe R, Horita T, Atsumi T, Matsukura M, Miyata T, Kochi Y, Suda T, Tanemoto K, Meguro A, Okada Y, Ogimoto A, Yamamoto M, Takahashi H, Nakayamada S, Saito K, Kuwana M, Mizuki N, Tabara Y, Ueda A, Komuro I, Kimura A, Isobe M, Mimori T, Matsuda F.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13045-13050. doi: 10.1073/pnas.1808850115. Epub 2018 Nov 29.

18.

Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.

Koga T, Sato T, Furukawa K, Morimoto S, Endo Y, Umeda M, Sumiyoshi R, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Kawakami A.

Arthritis Rheumatol. 2019 May;71(5):766-772. doi: 10.1002/art.40785. Epub 2019 Mar 20.

PMID:
30462889
19.

Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Agematsu K, Yachie A, Masumoto J, Migita K, Kawakami A.

Arthritis Res Ther. 2018 Nov 20;20(1):257. doi: 10.1186/s13075-018-1738-1.

20.

Paraneoplastic Syndrome Presenting with Polymyalgia Rheumatica-like Accumulations on 18F-fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.

Umetsu A, Shimizu T, Iwamoto N, Hashiguchi K, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Igawa T, Sumiyoshi R, Koga T, Kawashiri SY, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2019 Mar 15;58(6):861-864. doi: 10.2169/internalmedicine.1847-18. Epub 2018 Nov 19.

21.

Antineutrophilic cytoplasmic antibody-associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does not.

Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Tamai M, Ichinose K, Nakamura H, Origuchi T, Sato S, Kawakami A.

Int J Rheum Dis. 2019 May;22(5):789-796. doi: 10.1111/1756-185X.13422. Epub 2018 Nov 5.

PMID:
30398012
22.

Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis.

Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri SY, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Clin Immunol. 2018 Dec;197:161-168. doi: 10.1016/j.clim.2018.10.002. Epub 2018 Oct 5.

PMID:
30296591
23.

Evaluation of circulating invariant T cells before and after IL-17 inhibitor treatment in a patient with psoriatic arthritis.

Koga T, Matoba M, Sato T, Koike Y, Endo Y, Sumiyoshi R, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Clin Immunol. 2018 Dec;197:107-109. doi: 10.1016/j.clim.2018.09.011. Epub 2018 Sep 21. No abstract available.

PMID:
30248399
24.

Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.

Hara K, Endo Y, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Migita K, Kawakami A, Koga T.

Medicine (Baltimore). 2018 Sep;97(38):e12305. doi: 10.1097/MD.0000000000012305.

25.

Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.

Iwamoto N, Okamoto M, Tsuji S, Endo Y, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Igawa T, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Nakamura H, Origuchi T, Eguchi K, Ueki Y, Kawakami A.

J Bone Miner Metab. 2019 May;37(3):554-562. doi: 10.1007/s00774-018-0955-7. Epub 2018 Sep 5.

PMID:
30187273
26.

Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010.

Ichinose K, Shimizu T, Umeda M, Fukui S, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Sato S, Origuchi T, Kawakami A.

J Immunol Res. 2018 Aug 14;2018:6259010. doi: 10.1155/2018/6259010. eCollection 2018.

27.

Osteogenic differentiation of fibroblast-like synovial cells in rheumatoid arthritis is induced by microRNA-218 through a ROBO/Slit pathway.

Iwamoto N, Fukui S, Takatani A, Shimizu T, Umeda M, Nishino A, Igawa T, Koga T, Kawashiri SY, Ichinose K, Tmai M, Nakamura H, Origuchi T, Chiba K, Osaki M, Jüngel A, Gay S, Kawakami A.

Arthritis Res Ther. 2018 Aug 29;20(1):189. doi: 10.1186/s13075-018-1703-z.

28.

Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.

Shimizu T, Iwamoto N, Okamoto M, Endo Y, Tsuji S, Takatani A, Igawa T, Umeda M, Fukui S, Sumiyoshi R, Kitamura M, Koga T, Kawashiri SY, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Intern Med. 2019 Feb 1;58(3):441-445. doi: 10.2169/internalmedicine.1441-18. Epub 2018 Aug 24.

29.

Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis.

Fujita Y, Fukui S, Suzuki T, Ishida M, Endo Y, Tsuji S, Takatani A, Igawa T, Shimizu T, Umeda M, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Abe K, Kawakami A.

Intern Med. 2018 Dec 1;57(23):3473-3478. doi: 10.2169/internalmedicine.1121-18. Epub 2018 Jul 6.

30.

Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Hosono Y, Mimori T, Kawakami A.

Medicine (Baltimore). 2018 Jun;97(26):e11024. doi: 10.1097/MD.0000000000011024.

31.

Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.

Koga T, Umeda M, Endo Y, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Murakami N, Kitajima M, Kawakami A.

Int J Rheum Dis. 2018 Jun;21(6):1287-1292. doi: 10.1111/1756-185X.13318.

PMID:
29879312
32.

Serum complement factor C5a in IgG4-related disease.

Fukui S, Fujita Y, Origuchi T, Maeda T, Kawakami A.

Ann Rheum Dis. 2019 Jul;78(7):e65. doi: 10.1136/annrheumdis-2018-213705. Epub 2018 Jun 6. No abstract available.

PMID:
29875095
33.

Reversible Cognitive Dysfunction in Elderly-onset Systemic Lupus Erythematosus, Successfully Treated with Aggressive Immunosuppressive Therapy.

Fujita Y, Fukui S, Ishida M, Endo Y, Tsuji S, Takatani A, Igawa T, Shimizu T, Umeda M, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2018 Oct 15;57(20):3025-3028. doi: 10.2169/internalmedicine.0934-18. Epub 2018 May 18.

34.

The efficacy of adjunct tacrolimus treatment in pregnancy outcomes in patients with systemic lupus erythematosus.

Ichinose K, Sato S, Kitajima Y, Horai Y, Fujikawa K, Umeda M, Fukui S, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yasuhi I, Masuzaki H, Kawakami A.

Lupus. 2018 Jul;27(8):1312-1320. doi: 10.1177/0961203318770536. Epub 2018 Apr 17.

PMID:
29665758
35.

Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function.

Kawashiri SY, Nishino A, Igawa T, Takatani A, Shimizu T, Umeda M, Fukui S, Okada A, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakashima M, Mizokami A, Matsuoka N, Migita K, Ogawa F, Ikeda S, Maemura K, Nakamura H, Origuchi T, Maeda T, Kawakami A.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):102-108. Epub 2018 Apr 12.

36.

Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.

Endo Y, Koga T, Suzuki T, Hara K, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Kawakami A.

Medicine (Baltimore). 2018 Apr;97(15):e0436. doi: 10.1097/MD.0000000000010436.

37.

Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2018 Aug 1;57(15):2247-2250. doi: 10.2169/internalmedicine.0335-17. Epub 2018 Mar 9.

38.

Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in Japan.

Nishino A, Kawashiri SY, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Hamada H, Tsuru T, Nagano S, Arinobu Y, Hidaka T, Kawakami A.

Arthritis Care Res (Hoboken). 2018 Dec;70(12):1719-1726. doi: 10.1002/acr.23551.

PMID:
29481732
39.

Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.

Suzuki T, Fukui S, Umekita K, Miyamoto J, Umeda M, Nishino A, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Fujikawa K, Aramaki T, Mizokami A, Matsuoka N, Ueki Y, Eguchi K, Sato S, Hidaka T, Origuchi T, Okayama A, Kawakami A, Nakamura H.

Arthritis Rheumatol. 2018 Jul;70(7):1014-1021. doi: 10.1002/art.40461. Epub 2018 May 25.

40.

M1 and M2 Monocytes in Rheumatoid Arthritis: A Contribution of Imbalance of M1/M2 Monocytes to Osteoclastogenesis.

Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M, Nishino A, Horai Y, Hirai Y, Koga T, Kawashiri SY, Tamai M, Ichinose K, Nakamura H, Origuchi T, Masuyama R, Kosai K, Yanagihara K, Kawakami A.

Front Immunol. 2018 Jan 8;8:1958. doi: 10.3389/fimmu.2017.01958. eCollection 2017.

41.

Peripheral Ulcerative Keratitis Associated with Granulomatosis with Polyangiitis Emerging Despite Cyclophosphamide, Successfully Treated with Rituximab.

Fujita Y, Fukui S, Endo Y, Tsuji S, Takatani A, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki R, Uematsu M, Ishida K, Abe K, Kawakami A.

Intern Med. 2018 Jun 15;57(12):1783-1788. doi: 10.2169/internalmedicine.0215-17. Epub 2018 Jan 11.

42.

MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase γ pathway.

Koga T, Migita K, Sato T, Sato S, Umeda M, Nonaka F, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura KI, Eguchi K, Kawakami A.

Rheumatology (Oxford). 2018 Apr 1;57(4):718-726. doi: 10.1093/rheumatology/kex451.

PMID:
29294109
43.

The influence of aging on the effectiveness of heat stress in preventing disuse muscle atrophy.

Kataoka H, Nakano J, Kondo Y, Honda Y, Sakamoto J, Origuchi T, Okita M.

Physiol Int. 2017 Dec 1;104(4):316-328. doi: 10.1556/2060.104.2017.4.1.

PMID:
29278025
44.

Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus.

Ichinose K, Ohyama K, Furukawa K, Higuchi O, Mukaino A, Satoh K, Nakane S, Shimizu T, Umeda M, Fukui S, Nishino A, Nakajima H, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yoshida M, Kuroda N, Kawakami A.

Clin Immunol. 2018 Aug;193:123-130. doi: 10.1016/j.clim.2017.11.006. Epub 2017 Nov 21.

PMID:
29162406
45.

Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary Nodules.

Watanabe C, Fukui S, Iwamoto N, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Ichinose K, Hirai Y, Tamai M, Nakamura H, Origuchi T, Tabata K, Kawakami A.

Intern Med. 2018 Feb 1;57(3):417-421. doi: 10.2169/internalmedicine.9188-17. Epub 2017 Nov 1.

46.

CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosus.

Umeda M, Koga T, Ichinose K, Igawa T, Sato T, Takatani A, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Yamamoto K, Abiru N, Origuchi T, Ueki Y, Kawakami A.

Clin Immunol. 2018 Feb;187:50-57. doi: 10.1016/j.clim.2017.10.004. Epub 2017 Oct 13.

PMID:
29031579
47.

Comparison of serum inflammatory cytokine concentrations in familial Mediterranean fever and rheumatoid arthritis patients.

Koga T, Kawashiri SY, Migita K, Sato S, Umeda M, Fukui S, Nishino A, Nonaka F, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Eguchi K, Kawakami A.

Scand J Rheumatol. 2018 Jul;47(4):331-333. doi: 10.1080/03009742.2017.1363281. Epub 2017 Sep 2. No abstract available.

PMID:
28868950
48.

Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled.

Kawashiri SY, Fujikawa K, Nishino A, Okada A, Aramaki T, Shimizu T, Umeda M, Fukui S, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Mizokami A, Nakamura H, Origuchi T, Ueki Y, Aoyagi K, Maeda T, Kawakami A.

Arthritis Res Ther. 2017 May 25;19(1):108. doi: 10.1186/s13075-017-1320-2.

49.

Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.

Koga T, Okada A, Fukuda T, Hidaka T, Ishii T, Ueki Y, Kodera T, Nakashima M, Takahashi Y, Honda S, Horai Y, Watanabe R, Okuno H, Aramaki T, Izumiyama T, Takai O, Miyashita T, Sato S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Aoyagi K, Eguchi K, Kawakami A; Japanese RA Patients with RRP Study Group.

PLoS One. 2017 May 15;12(5):e0175281. doi: 10.1371/journal.pone.0175281. eCollection 2017.

50.

Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.

Iwamoto N, Tsuji S, Takatani A, Shimizu T, Fukui S, Umeda M, Nishino A, Horai Y, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Hirai Y, Tamai M, Nakamura H, Terada K, Origuchi T, Eguchi K, Ueki Y, Kawakami A.

PLoS One. 2017 May 4;12(5):e0177057. doi: 10.1371/journal.pone.0177057. eCollection 2017.

Supplemental Content

Loading ...
Support Center